The most prominent name in the mass exodus is that of its CFO Rajesh Garg, who quit to pursue his entrepreneurial ambitions. Company CEO Subhanu Saxena is overseeing finance functions in the interim.
Rajesh Garg, global chief financial officer, Cipla, told CNBC-TV18 that operating profits were impacted in the absence of anti-depressant Escitalopram sales in the US, and higher sales of anti-retroviral (ARV) drugs, where profit margins are low.